מדינה: אוסטרליה
שפה: אנגלית
מקור: Department of Health (Therapeutic Goods Administration)
risperidone, Quantity: 0.5 mg
Medis Pharma Pty Ltd
Risperidone
Tablet, film coated
Excipient Ingredients: colloidal anhydrous silica; iron oxide red; lactose monohydrate; hypromellose; magnesium stearate; microcrystalline cellulose; maize starch; titanium dioxide; macrogol 400
Oral
30 tablets, 60 tablets, 100 tablets, 15 tablets, 20 tablets
(S4) Prescription Only Medicine
Risperidone-AS is indicated for the treatment of schizophrenia and related psychoses. Risperidone-AS is indicated for the treatment of behavioural disturbances in dementia. Risperidone-AS is indicated for the treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent. (See Clinical Trials for maintenance data).
Visual Identification: Red, film-coated, round tablet with "R" engraved on one face and a breakline on the other.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2012-09-26